Tuesday 16 November 2010 9:21 pm KCS-content AN ADVISORY panel for the US Food and Drug Administration (FDA) last night recommended that the agency approve a new treatment for lupus developed by GlaxoSmithKline (Glaxo) with peer Human Genome Sciences.The committee voted 13-2 in favor of a drug called Benlysta – which analysts estimate could see annual global sales of $2.2bn by 2014 and exceed $5bn by 2020. Profits from the drug would be split equally between currently unprofitable biotech firm Human Genome and Glaxo.The FDA, which should make a decision by early December, isn’t required to follow the advice of its panels, but usually does.Benlysta is important for both companies as it’s one of the most important new drugs in Glaxo’s pipeline and Human Genome has no products on the market.The drug’s success in two large studies has produced consistent speculation that Glaxo would acquire Human Genome.There have been no new treatments in the last few decades for lupus, a disease in which the body’s immune system attacks its own organs and tissues and is most often seen in women of child-bearing age.Symptoms can include fever, swollen joints, skin rashes and severe damage of the kidneys, lungs or central nervous system. US-listed Glaxo’s shares gained 3.4 per cent to $39.85 in after-hours US trading. whatsapp whatsapp Glaxo’s lupus drug cleared by US panel Tags: NULL More From Our Partners Florida woman allegedly crashes children’s birthday party, rapes teennypost.comBrave 7-Year-old Boy Swims an Hour to Rescue His Dad and Little Sistergoodnewsnetwork.orgFeds seized 18 devices from Rudy Giuliani and his employees in April raidnypost.comA ProPublica investigation has caused outrage in the U.S. this weekvaluewalk.comI blew off Adam Sandler 22 years ago — and it’s my biggest regretnypost.comRussell Wilson, AOC among many voicing support for Naomi Osakacbsnews.comNative American Tribe Gets Back Sacred Island Taken 160 Years Agogoodnewsnetwork.orgPolice Capture Elusive Tiger Poacher After 20 Years of Pursuing the Huntergoodnewsnetwork.orgAstounding Fossil Discovery in California After Man Looks Closelygoodnewsnetwork.orgWhy people are finding dryer sheets in their mailboxesnypost.comInside Ashton Kutcher and Mila Kunis’ not-so-average farmhouse estatenypost.comMark Eaton, former NBA All-Star, dead at 64nypost.comKiller drone ‘hunted down a human target’ without being told tonypost.comBiden received funds from top Russia lobbyist before Nord Stream 2 giveawaynypost.comSupermodel Anne Vyalitsyna claims income drop, pushes for child supportnypost.comMatt Gaetz swindled by ‘malicious actors’ in $155K boat sale boondogglenypost.com‘The Love Boat’ captain Gavin MacLeod dies at 90nypost.comUK teen died on school trip after teachers allegedly refused her pleasnypost.com Share by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May LikeTotal PastThe Ingenious Reason There Are No Mosquitoes At Disney WorldTotal PastSerendipity TimesInside Coco Chanel’s Eerily Abandoned Mansion Frozen In TimeSerendipity TimesBlood Pressure Solution4 Worst Blood Pressure MedsBlood Pressure Solutionmoneycougar.comThis Proves The Osmonds Weren’t So Innocentmoneycougar.comBlood Pressure For LifeWhy Doctors May No Longer Prescribe Blood Pressure MedsBlood Pressure For LifeLiver Health1 Bite of This Melts Belly And Arm Fat (Take Before Bed)Liver HealthTaonga: The Island FarmThe Most Relaxing Farm Game of 2021. No InstallTaonga: The Island FarmAlphaCute30 Rules That All “Hells Angels” Have To FollowAlphaCuteWolf & ShepherdNFL Star Rob Gronkowski Loves These ShoesWolf & Shepherd Show Comments ▼
Tags: NULL Shareholders to decide fate of De La Rue by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May LikeMisterStoryWoman Files For Divorce After Seeing This Photo – Can You See Why?MisterStoryMoneyPailShe Was A Star, Now She Works In ScottsdaleMoneyPailTotal PastThe Ingenious Reason There Are No Mosquitoes At Disney WorldTotal PastSerendipity TimesInside Coco Chanel’s Eerily Abandoned Mansion Frozen In TimeSerendipity TimesBrake For ItThe Most Worthless Cars Ever MadeBrake For ItBetterBe20 Stunning Female AthletesBetterBeHistorical GeniusHe Was The Smartest Man Who Ever Lived – But He Led A Miserable LifeHistorical GeniusElite HeraldExperts Discover Girl Born From Two Different SpeciesElite Heraldmoneycougar.comThis Proves The Osmonds Weren’t So Innocentmoneycougar.com Share Read This Next’A Quiet Place Part II’ Sets Pandemic Record in Debut WeekendFamily ProofHiking Gadgets: Amazon Deals Perfect For Your Next AdventureFamily ProofYoga for Beginners: 3 Different Types of Yoga You Should TryFamily ProofIndian Spiced Vegetable Nuggets: Recipes Worth CookingFamily ProofAmazon roars for MGM’s lion, paying $8.45 billion for studio behind JamesFamily ProofThe Truth About Bottled Water – Get the Facts on Drinking Bottled WaterGayotBack on the Rails for Summer New York to New Orleans, Savannah and MiamiFamily ProofChicken Bao: Delicious Recipes Worth CookingFamily ProofCheese Crostini: Delicious Recipes Worth CookingFamily Proof whatsapp whatsapp Tuesday 4 January 2011 8:05 pm Show Comments ▼ KCS-content Oberthur’s overtures to De La Rue’s shareholders have just begunTHE fate of British money-printer De La Rue lies in its shareholders’ hands this week, as Oberthur Technologies tries to sell them on its takeover bid of 905p, worth £895m in total.Oberthur, which is being advised by Lazard & Co and HSBC, upped the stakes yesterday by claiming that De La Rue has lost its biggest client, without which some analysts have said it would be worth only 620p per share.Shareholders will have to decide whether to hold out for more when they could take a safe bet at £9.Oberthur has tried to boost its appeal further by promising not to take jobs abroad if it gets control of the UK firm, which prints sterling banknotes for the Bank of England.In its statement yesterday, it said: “Oberthur intends to maintain the production of all sterling banknotes in the UK.” However, the company would not make a commitment on the production of passports. Unite the union said in December that it was opposed to the French takeover. De La Rue’s biggest shareholders include Capital World Investors, which owns 15 per cent, Prudential, which has 12 per cent, and Capital Research and Management, which owns nine per cent of its stock. The company is advised by JP Morgan Cazenove and Rothschild.